Abiomed Overview

  • Year Founded
  • 1981

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 2,000

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 8

  • Investments
  • 21

Abiomed General Information

Description

Developer of medical devices that provides circulatory and respiratory support by enabling the heart to rest and recover by improving blood flow and temporarily assisting with the pumping function. The company offers temporary mechanical circulatory support devices that are primarily used by interventional cardiologists and heart surgeons. The firm's products are used for patients in need of hemodynamic support before, during, or after angioplasty and heart surgery procedures. Abiomed receives the majority of revenue from its Impella product portfolio, which includes percutaneous micro heart pumps with integration motors and sensors and percutaneous catheter-based axial flow pumps. Abiomed generates the majority of its revenue in the United States.

Contact Information

Website
www.abiomed.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 22 Cherry Hill Drive
  • Danvers, MA 01923
  • United States
+1 (978)
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Parent Company
Johnson & Johnson
Former Stock Listing
ABMD
Corporate Office
  • 22 Cherry Hill Drive
  • Danvers, MA 01923
  • United States
+1 (978)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Abiomed Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Abiomed‘s full profile, request access.

Request a free trial

Abiomed Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of medical devices that provides circulatory and respiratory support by enabling the heart to rest and recover
Therapeutic Devices
Danvers, MA
2,000 As of 2024

Oxford, United Kingdom
 

Marlborough, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Abiomed Competitors (48)

One of Abiomed’s 48 competitors is OrganOx, a Formerly PE-Backed company based in Oxford, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
OrganOx Formerly PE-Backed Oxford, United Kingdom
Boston Scientific Corporation Marlborough, MA
CardioRenal Systems Venture Capital-Backed Milford, MA
Globus Medical Formerly VC-backed Audubon, PA
BiVACOR Venture Capital-Backed Huntington Beach, CA
You’re viewing 5 of 48 competitors. Get the full list »

Abiomed Patents

Abiomed Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260325820-A1 Flexible rotor blade for a right sided heart pump Pending 18-Apr-2025
WO-2026220361-A1 Flexible rotor blade for a right sided heart pump Pending 18-Apr-2025
WO-2026220356-A1 Medical cart Pending 17-Apr-2025
US-20260355496-A1 Methods and systems for monitoring patient movement Pending 17-Apr-2025
WO-2026220354-A1 Methods and systems for monitoring patient movement field of the invention Pending 17-Apr-2025 A61B5/746
To view Abiomed’s complete patent history, request access »

Abiomed Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Abiomed Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Abiomed‘s full profile, request access.

Request a free trial

Abiomed Investments & Acquisitions (21)

Abiomed’s most recent deal was a Later Stage VC with Vivasure Medical for . The deal was made on 14-Mar-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Vivasure Medical 14-Mar-2023 Later Stage VC Surgical Devices
Reprieve Cardiovascular 07-Jun-2022 Early Stage VC Biotechnology
Impulse Dynamics 23-May-2022 Later Stage VC Therapeutic Devices
PreCardia 28-May-2021 Merger/Acquisition Other Devices and Supplies
Magenta Medical 19-Apr-2021 Later Stage VC Therapeutic Devices
You’re viewing 5 of 21 investments and acquisitions. Get the full list »

Abiomed Exits (5)

Abiomed’s most recent exit was on 14-Mar-2023 from Vivasure Medical. The exit was categorized as with 10 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Vivasure Medical 14-Mar-2023 Completed
  • 10 buyers
CathWorks 16-Dec-2020 Completed
  • 6 buyers
ShockWave Medical 11-Mar-2019 Completed
ShockWave Medical 12-Dec-2018 Completed
  • 4 buyers
ALung 12-Dec-2017 Later Stage VC Completed
  • 8 buyers
To view Abiomed’s complete exits history, request access »

Abiomed Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Abiomed R&d Danvers, MA 1993

Abiomed FAQs

  • When was Abiomed founded?

    Abiomed was founded in 1981.

  • Where is Abiomed headquartered?

    Abiomed is headquartered in Danvers, MA.

  • What is the size of Abiomed?

    Abiomed has 2,000 total employees.

  • What industry is Abiomed in?

    Abiomed’s primary industry is Therapeutic Devices.

  • Is Abiomed a private or public company?

    Abiomed is a Private company.

  • What is the current valuation of Abiomed?

    The current valuation of Abiomed is .

  • What is Abiomed’s current revenue?

    The current revenue for Abiomed is .

  • How much funding has Abiomed raised over time?

    Abiomed has raised $20.1M.

  • Who are Abiomed’s investors?

    Balasa Dinverno Foltz, Cutler Investment Group, EW Healthcare Partners, Forbion, and Juncture Wealth Strategies are 5 of 7 investors who have invested in Abiomed.

  • Who are Abiomed’s competitors?

    OrganOx, Boston Scientific, CardioRenal Systems, Globus Medical, and BiVACOR are some of the 48 competitors of Abiomed.

  • When was Abiomed acquired?

    Abiomed was acquired on 22-Dec-2022.

  • Who acquired Abiomed?

    Abiomed was acquired by Johnson & Johnson.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process